State-of-the-art: Inflammatory and metabolic markers in mood disorders

16Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Mounting evidence highlights the involvement of inflammatory/immune systems and their relationships with neurotransmitters and different metabolic processes in mood disorders. Nevertheless, there is a general agreement that available findings are still inconclusive. Therefore, further investigations are required, aimed at deepening the role of possible alterations of biomarkers in the pathophysiology of mood disorders that might lead to more focused and tailored treatments. The present study is a comprehensive review on these topics that seem to represent intriguing avenues for the development of real innovative therapeutic strategies of mood disorders.

Cite

CITATION STYLE

APA

Mucci, F., Marazziti, D., Vecchia, A. D., Baroni, S., Morana, P., Carpita, B., … Dell’osso, L. (2020, June 1). State-of-the-art: Inflammatory and metabolic markers in mood disorders. Life. MDPI AG. https://doi.org/10.3390/life10060082

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free